Gemina Laboratories Ltd.
GLAB
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.75% | 57.42% | 11.99% | -77.21% | 26.87% |
| Total Depreciation and Amortization | -91.20% | -89.80% | 4.55% | 7.61% | 6.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.56% | -103.86% | -16.33% | 255.73% | -72.93% |
| Change in Net Operating Assets | -34.07% | -21.73% | 658.86% | 11.73% | 17.85% |
| Cash from Operations | 119.30% | 89.70% | 103.71% | -513.11% | 35.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 8.33% | -- |
| Total Debt Issued | -- | -- | -- | -- | -75.00% |
| Total Debt Repaid | -12.06% | 100.00% | 62.45% | -18.18% | -16.67% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 337.70% | -- | 46.69% | -- | -- |
| Cash from Financing | -287.50% | -100.00% | -102.01% | 15.82% | -93.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.26% | -114.29% | 1,900.00% | -1,957.14% | -46.49% |